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Clearly defined antibiotic protocols to guide empirical
therapy are available but need to be reinforced via regular
education of and feedback to all doctors. An antibiotic phar-
macist has recently been appointed at Beaumont Hospital, in
accordance with a national strategy for the control of antibi-
otic resistance [6]. This individual has a key role in ensuring
compliance with antibiotic guidelines, education of medical
staff, and regular audit of antibiotic prescribing. Although
there is a significant history of antibiotic stewardship in
Beaumont Hospital [7,8], these data emphasize the need for
daily review of the need for continued antibiotic treatment
by a senior doctor (i.e. at the consultant level), a microbiolo-
gist, or an infectious disease physician.
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Abstract
Knowledge about seasonal trends in acute toxoplasmosis in
pregnancy may help to understand and avoid risk factors for
infection. Analysing regular screening records of 51 754 pregnant
women, members of the largest statutory health insurance com-
pany in the federal state of Upper Austria from 2000 to 2005,
we found a twofold increase of diagnoses of acute toxoplasmosis
during winter months. Taking the delay between infection and
screening into account, the increased number of detections in
winter points towards more frequent infections in autumn. We
propose a higher consumption of contaminated vegetables and
fruit from gardening as one of the potential explanations.
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Acute toxoplasmosis in pregnant women carries a risk of
infection for the unborn that might result in moderate to
severe ocular and neurological disorders [1]. Secondary pre-
vention using general screening during pregnancy and antimi-
crobial treatment is cumbersome, still disputed and offered
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free to all pregnant women only in few European countries,
i.e. France, Austria, Italy and Slovenia [2–4]. Pregnant women
should be advised to avoid risk factors for infection, espe-
cially eating of undercooked meat and contact with soil (mul-
ticentre case–control study by Cook et al. [5]: population
attributable risk of 30–63% and 6–17%, respectively). Many
infections (14–49%) cannot yet be completely explained by
known risk factors. A recent study from Slovenia reported a
significant increase during winter months in the incidence of
acute toxoplasmosis detected by screening in pregnant
women [6]. We used a dataset from the federal state of
Upper Austria to corroborate this finding in a different pop-
ulation. Upper Austria is characterized by a transitional cli-
mate between mild and continental zones, with average
temperatures during summer months around 20C and close
to 0C in winter. There is sufficient precipitation throughout
the year (annual average 1000 mm).
We retrospectively investigated records from toxoplasmo-
sis screening of pregnant women participating in the mother–
child-booklet (http://www.help.gv.at/Content.Nock/143/Seite.
1430100.html#child) preventive programme. The analysis
included 51 754 women who were members of the largest
statutory health insurance company in Upper Austria
(OO¨GKK—Obero¨sterreichische Gebietskrankenkasse) and
screened between 1 January 2000 and 31 December 2005.
The indirect immunofluorescence test (IIFT) was used for
screening to detect specific antibodies of all immunoglobulin
classes. In case of seropositivity (titre ‡1:16) a second speci-
men collected >2 weeks later was checked for any titre rise. If
the titre increased or if it was ‡1:64 already in the first test, an
IgM test (VIDAS TOXO IgM) was performed, and if this IgM
test was not clearly negative, an IgG avidity test (VIDAS
TOXO IgG AVIDITY) was carried out. A negative result for
IgM or positive IgM but high avidity index was assumed to rule
out acute infection (all tests from bioMe´rieux, Marcy-l’Etoile,
France; before October 2004 an in-house IIFT test was used).
A case was regarded as a ‘suspected case’ if the test con-
stellation was: IIFT positive, IgM positive and avidity low. If
seroconversion or a more than fourfold titre rise in IIFT
during pregnancy had occurred, we classified the case as a
‘certain case’. Based on these definitions, suspected cases
included also certain cases. We used locally weighted regres-
sion to visualize the changes in weekly incidence of toxoplas-
mosis over time and to estimate the seasonal trend during a
calendar year. Since the overall number of examinations did
not change over the studied period, we used Poisson
distribution to model the incidence of toxoplasmosis cases.
The analysis was conducted with R-library gam [7].
In total, there were 191 suspected cases, including 51 cer-
tain cases of acute toxoplasmosis infections in our study
population. In 45 of the 51 certain cases seroconversion was
observed. There was substantial variability across time in the
weekly incidence of suspected cases, with a higher incidence
during the winter months (Fig. 1). This was confirmed in the
seasonal trend analysis, with a more than two times higher
incidence of toxoplasmosis during the winter months (Fig. 2,
p-value <0.05 in likelihood ratio test). This result remained
unchanged when additionally calendar years were taken into
account (data not shown). Across years there was a falling
trend in the number of cases with borderline evidence sup-
porting higher incidence in every second year (Fig. 1). The
results were similar when the analysis was restricted only to
certain cases (data not shown). In the cases when serocon-
versions (n = 45) were documented, the mean duration
between the last seronegative and the first seropositive
result was 102 days (range 30–181 days).
Our findings confirm the seasonality in diagnosis of acute
toxoplasmosis infections during pregnancy observed by Logar
et al. [6] in Slovenia using an independent sample from Upper
Austria. Some previous studies have reported different sea-
sonal patterns [8–10], but these studies either did not
FIG. 1. Weekly incidence of acute toxoplasmosis during the study
period (suspected cases, dotted lines indicate 95% confidence inter-
vals, x-axis in weeks with numbers indicating the beginning of the
corresponding year).
FIG. 2. Seasonal trend in acute toxoplasmosis incidence (suspected
cases, dotted lines indicate 95% confidence intervals, x-axis in weeks
with abbreviations indicating the beginning of the corresponding
month).
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directly refer to pregnant women or drew only indirect con-
clusions on the most probable time point of infection in
pregnancy from postnatally diagnosed neurological or ocular
disorders, and therefore are not directly comparable to our
data.
While the temporal increase in the number of cases diag-
nosed during screening observed by us and Logar et al. [6]
occurred in winter, it is likely that the increase of infections
occurs earlier in the calendar year, most likely in autumn.
Since acute toxoplasmosis is asymptomatic in adults, the
infection does not affect the timing of screening. Given that
elevated IgM persists for several months, a short period of
increased infections will be reflected in several months with
higher numbers of detections starting after the infection per-
iod. The period until IgM can be detected (1–2 weeks) con-
tributes only little to this delay [11].
Therefore, we suggest that a specific risk factor associated
with autumn rather than winter has to be identified. One of
the potential explanations could be a higher consumption of
vegetables and fruit from hobby gardens and organic farming
during autumn, because contamination of the soil and its
products by infected cats may be more likely in these settings
than in industrial-style farming. Furthermore, the increased
risk could be caused by mild temperatures in autumn, facili-
tating survival of toxoplasma oocysts. Our data do not allow
testing the hypothesis, and the large study by Cook et al. [5]
did not assess this potential association. The twofold risk
increase observed in our study warrants further studies in
order to prove and explain the association.
In addition to the seasonal trend, we observed an overall
decrease in the incidence of acute toxoplasmosis and possi-
bly a bi-yearly rhythm with a higher incidence in the alter-
nate years. However, both phenomena are difficult to judge
based on the short time period (just six units of analysis,
while the seasonal analysis was based on 6 times 52 weeks).
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